Tag: Novartis
-
Beovu Drug Label Change in December 2021 Adds More Information About Vision Loss Side Effects
Provides "risk factors and possible mechanism" for Beovu-related Retinal Vasculitis and Retinal Vascular Occlusion (Posted by Tom Lamb at Drug Injury Watch) Update: "Novartis Finally Issues Revised Beovu Prescribing Information for US in February 2022"…
-
Beovu Vision Loss Side Effects Continue to Plague Novartis, Ending 3 Key Clinical Trials in May 2021
And Novartis "has yet to identify the root cause behind Beovu’s safety problem", According to a News Report (Posted by Tom Lamb at Drug Injury Watch) Starting back in February 2020, when the American Society…
-
Beovu Vision Loss Lawsuits Involve Serious Eye Problems Due to Beovu Injections Reactions
People Need to Know Beovu Lawsuits Are Filed as Individual Cases; No Beovu Class Actions for Beovu Eye Problems (Posted by Tom Lamb at Drug Injury Watch) Starting in January 2021 Beovu…
-
Beovu Side Effects Have Caused Eye Doctors to Avoid Beovu and Use Other Safer AMD Drugs Instead
In Addition, the Three New Beovu Lawsuits Filed for Patients with Vision Loss May Further Impact Novartis Market Share (Posted by Tom Lamb at Drug Injury Watch) Since being approved by the…
-
Gilenya Safety Alert November 2020: Cases of Acute Liver Failure Requiring Liver Transplant
European Medicines Agency (EMA) and Novartis Issue Dear Doctor Letter About Gilenya Label Change (Posted by Tom Lamb at DrugInjuryWatch.com) A recent periodic review of Gilenya safety data by the European Medicines…
-
Beovu Lawsuits Filed Against Novartis for Patients Who Have Suffered Vision Loss Side Effects
Beovu Legal Cases Involve Retinal Artery Occlusion, Retinal Vasculitis, Intraocular Inflammation, Other Eye Problems (Posted by Tom Lamb at DrugInjuryWatch.com) Beovu (brolucizumab) is prescribed for the treatment of neovascular (wet) age-related macular…
-
Beovu: Should Use of This Eye Drug be Suspended Until Safety Investigation is Finished?
Numerous Case Reports of Occlusive Retinal Vasculitis and Vision Loss in Patients Following Beovu Injections (Posted by Tom Lamb at DrugInjuryWatch.com) As early as May 2020 it was suggested by the authors…